Total Revenue

+16% YoY

Total Revenue increased from $606.56 million in Q1 2024 to $702.889 million in Q1 2025. This improvement is driven by strong performance in the outpatient medical and lab segments due to merger integration, enhanced leasing activity, and elevated occupancy rates, building on previous period momentum. " "

Net Income

+347% YoY

Net income surged from $11.177 million in Q1 2024 to $50.064 million in Q1 2025. The dramatic jump reflects a significant reduction in merger-related and transaction costs, lower interest expenses—partly due to debt repayment actions—and improved operating margins compared to the prior period. " "

Income before Taxes

+141% YoY

Income before taxes increased from $22.499 million in Q1 2024 to $54.291 million in Q1 2025. This rise stems from higher adjusted net operating income from core segments, decreased loan loss reserves, and reduced merger-associated expenses, marking an improvement over last year's financial profile. " "